Compared with primary total knee arthroplasty, revision unicompartmental knee arthroplasty was correlated with poorer outcomes; however, researchers theorized this may have been a result of poorer preoperative function.
Most patients’ brake reaction time had returned to baseline level or better within 2 weeks of undergoing total hip arthroplasty, allowing the patients to be able to drive safely again, according to study results.
This study was designed to assess the use of platelet-rich plasma (PRP) during primary total knee arthroplasty (TKA). The authors hypothesized that this would result in less blood loss and greater hemoglobin and hematocrit levels at discharge and would potentially decrease the length of hospital stay. Leukocyte rich PRP was used during the procedure and at wound closure. Two surgeons performed all procedures in a similar fashion. Two different TKA implants were used. Each surgeon used the same implant throughout the study. A limited medial parapatellar approach was used and drains were used at closure. No tranexamic acid preparations were used. Continuous passive motion machines were used in all patients during their hospital stay.
Source: Medical Xpress
Surgery to replace the arthritic hip and knee joints is on the rise in the U.S., with more than 1.1 million replacement surgeries reported in 2009. While these surgeries improve pain, mobility and quality of life for most recipients, some patients are dogged by persistent muscular problems. Now, a cross-institutional team of researchers has found that a patient’s susceptibility to muscle inflammation may be a measurable marker that can be used to predict how well that patient will recover from joint replacement surgery and to identify those patients who may be in need of a specialized rehabilitation plan.
Source: Medical Xpress
While women may have their first total joint replacement (TJR) at an older age, they are less likely to have complications related to their surgery or require revision surgery, according to a new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The findings contradict the theory that TJR is underutilized in female patients because they have worse outcomes then men.